Home › Alopecia Areata › Texas
Alopecia Areata clinical trials in Texas
7 studies for Alopecia Areata are looking for participants at sites in Texas.
Cities in Texas
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
- Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue, San Antonio
RecruitingPhase 2
Ages 18 to 60 · All sexes · Updated Nov 4, 2026 · NCT07533006A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- 3A Research - East location /ID# 283404, El Paso
- Texas Dermatology and Laser Specialists /ID# 282813, San Antonio
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 27, 2026 · NCT07772492A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Center for Clinical Studies, LTD. LLP, Houston
- Texas Dermatology and Laser Specialists, San Antonio
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Oct 26, 2026 · NCT07733765A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- The University of Texas Health Science Center at Houston, Bellaire
- Center for Clinical Studies, Houston
- Texas Dermatology and Laser Specialists, San Antonio
- and 1 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Oct 20, 2026 · NCT06873945A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Arlington Research Center, Inc /ID# 258028, Arlington
- Bellaire Dermatology Associates /ID# 259360, Bellaire
- U.S. Dermatology Partners - Cedar Park /ID# 259367, Cedar Park
- and 1 more
RecruitingPhase 3
Ages 12 to 63 · All sexes · Updated Oct 19, 2026 · NCT06012240A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- Dell Children's Medical Center, Austin
- Driscoll Children's Hospital, Corpus Christi
- 3A Research, El Paso
- and 2 more
RecruitingPhase 3
Ages 6 to 14 · All sexes · Updated Oct 15, 2026 · NCT07029828Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Dermatology Treatment And Research Center - Dallas, Dallas
- North Texas Center For Clinical Research, Frisco
- Austin Institute For Clinical Research Inc., Pflugerville
- and 1 more
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Jan 28, 2026 · NCT07133308From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.